Alan D. Friedman

8.3k total citations · 2 hit papers
128 papers, 7.0k citations indexed

About

Alan D. Friedman is a scholar working on Molecular Biology, Hematology and Immunology. According to data from OpenAlex, Alan D. Friedman has authored 128 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Molecular Biology, 56 papers in Hematology and 38 papers in Immunology. Recurrent topics in Alan D. Friedman's work include Acute Myeloid Leukemia Research (55 papers), Immune Response and Inflammation (17 papers) and Immune cells in cancer (16 papers). Alan D. Friedman is often cited by papers focused on Acute Myeloid Leukemia Research (55 papers), Immune Response and Inflammation (17 papers) and Immune cells in cancer (16 papers). Alan D. Friedman collaborates with scholars based in United States, Italy and China. Alan D. Friedman's co-authors include Steven L. McKnight, Robert M. Umek, William Landschulz, Tanawan Kummalue, Hong Guo, Issarang Nuchprayoon, Joseph Suzow, Qian-Fei Wang, Ido Paz‐Priel and Scott W. Hiebert and has published in prestigious journals such as Science, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Alan D. Friedman

127 papers receiving 6.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CCAAT-Enhancer Binding Protein: A Component of a Differentiation Switch

1991 648 citations Alan D. Friedman et al. profile →
Differentiation-induced gene expression in 3T3-L1 preadipocytes: CCAAT/enhancer binding protein interacts with and activates the promoters of two adipocyte-specific genes.

1989 531 citations Alan D. Friedman et al. profile →

Peers

Countries citing papers authored by Alan D. Friedman

Since Specialization

Citations

This map shows the geographic impact of Alan D. Friedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan D. Friedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan D. Friedman more than expected).

Fields of papers citing papers by Alan D. Friedman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan D. Friedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan D. Friedman. The network helps show where Alan D. Friedman may publish in the future.

Co-authorship network of co-authors of Alan D. Friedman

This figure shows the co-authorship network connecting the top 25 collaborators of Alan D. Friedman. A scholar is included among the top collaborators of Alan D. Friedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan D. Friedman. Alan D. Friedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	HoxA9 binds and represses the Cebpa +8 kb enhancer 2019 ·PLoS ONE ·Lei Peng, Hong Guo-Parke, Peilin Ma, Yuqing Sun, Lauren Dennison, Peter D. Aplan, Jay L. Hess, Alan D. Friedman	4
2	RUNX1 and CBFβ Mutations and Activities of Their Wild-Type Alleles in AML 2017 ·Advances in experimental medicine and biology ·R. Katherine Hyde, Paul Liu, Alan D. Friedman	9
3	Tankyrase inhibition promotes a stable human naïve pluripotent state with improved functionality 2016 ·Development ·Ludovic Zimmerlin, Tea Soon Park, Jeffrey S. Huo, (unknown), Sarshan R. Pather, C. Conover Talbot, (unknown), Diana Steppan, Yang W. Zhang, Michael Considine, Hongchao Guo, Xiufeng Zhong, Christian Gutierrez, Leslie Cope, Marta Soler, Alan D. Friedman, Stephen B. Baylin, Elias T. Zambidis	62
4	A review of the literature for intra-arterial chemotherapy used to treat retinoblastoma 2016 ·Pediatric Radiology ·Emily Wyse, James T. Handa, Alan D. Friedman, Monica S. Pearl	41
5	In Vivo Deletion of the Cebpa +37 kb Enhancer Markedly Reduces Cebpa mRNA in Myeloid Progenitors but Not in Non-Hematopoietic Tissues to Impair Granulopoiesis 2016 ·PLoS ONE ·Hong Guo, (unknown), Alan D. Friedman	22
6	C/EBPα, C/EBPα Oncoproteins, or C/EBPβ Preferentially Bind NF-κB p50 Compared with p65, Focusing Therapeutic Targeting on the C/EBP:p50 Interaction 2011 ·Molecular Cancer Research ·(unknown), Ido Paz‐Priel, Simone Houng, Albert S. Baldwin, Alan D. Friedman	17
7	NF-κB p50 Regulates C/EBPα Expression and Inflammatory Cytokine-Induced Neutrophil Production 2009 ·The Journal of Immunology ·Dehua Wang, Ido Paz‐Priel, Alan D. Friedman	58
8	Extending the Application of Tubeless Percutaneous Nephrolithotomy 2007 ·Urology ·Mario Sofer, Avi Beri, Alan D. Friedman, Galit Aviram, (unknown), Juza Chen, Jacob Ben‐Chaim, Alexander Greenstein, Haim Matzkin	33
9	CBFβ-SMMHC slows proliferation of primary murine and human myeloid progenitors 2005 ·Leukemia ·Jenice D’Costa, (unknown), Curt I. Civin, Alan D. Friedman	13
10	The CCAAT Enhancer-binding Protein (C/EBP)β and Nrf1 Interact to Regulate Dentin Sialophosphoprotein (DSPP) Gene Expression during Odontoblast Differentiation 2004 ·Journal of Biological Chemistry ·Karthikeyan Narayanan, Amsaveni Ramachandran, (unknown), Jianjun Hao, Anne-Brit Kolstø, Alan D. Friedman, Anne George	45
11	c-Myc Overcomes Cell Cycle Inhibition by CBFβ-SMMHC 2002 ·Cancer Biology & Therapy ·(unknown), Yandan Yang, (unknown), Alan D. Friedman	11
12	TEL-AML1, expressed from t(12;21) in human acute lymphocytic leukemia, induces acute leukemia in mice. 2002 ·PubMed ·(unknown), Yandan Yang, (unknown), Marianna Zahurak, Linzhao Cheng, Curt I. Civin, Alan D. Friedman	75
13	Multimerization via Its Myosin Domain Facilitates Nuclear Localization and Inhibition of Core Binding Factor (CBF) Activities by the CBFβ-Smooth Muscle Myosin Heavy Chain Myeloid Leukemia Oncoprotein 2002 ·Molecular and Cellular Biology ·Tanawan Kummalue, (unknown), Alan D. Friedman	24
14	Multiple Functional Domains of AML1: PU.1 and C/EBPα Synergize with Different Regions of AML1 1998 ·Molecular and Cellular Biology ·Martha Petrovick, Scott W. Hiebert, Alan D. Friedman, Christopher J. Hetherington, Daniel G. Tenen, Dong‐Er Zhang	192
15	The Core Binding Factor (CBF) α Interaction Domain and the Smooth Muscle Myosin Heavy Chain (SMMHC) Segment of CBFβ-SMMHC Are Both Required to Slow Cell Proliferation 1998 ·Journal of Biological Chemistry ·Wangsen Cao, Neeraj Adya, (unknown), Peiqing Liu, Alan D. Friedman	38
16	Core Binding Factor Cannot Synergistically Activate the Myeloperoxidase Proximal Enhancer in Immature Myeloid Cells without c-Myb 1997 ·Molecular and Cellular Biology ·(unknown), Alan D. Friedman	81
17	CBFβ-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells 1997 ·Oncogene ·Wangsen Cao, (unknown), David F. Claxton, Christine A. Kelley, Nancy A. Speck, Peiqing Liu, Alan D. Friedman	71
18	The myeloperoxidase gene proximal enhancer directs hematopoietic-specific expression in transgenic mice 1997 ·Gene ·Sérgio A. Lira, Alan D. Friedman	1
19	C/EBP, c-Myb, and PU.1 Cooperate To Regulate the Neutrophil Elastase Promoter 1996 ·Molecular and Cellular Biology ·Michael Oelgeschläger, Issarang Nuchprayoon, Bernhard Lüscher, Alan D. Friedman	207
20	PEBP2/CBF, the Murine Homolog of the Human Myeloid AML1 and PEBP2β/CBFβ Proto-oncoproteins, Regulates the Murine Myeloperoxidase and Neutrophil Elastase Genes in Immature Myeloid Cells 1994 ·Molecular and Cellular Biology ·Issarang Nuchprayoon, Shari Meyers, Linda M. Scott, Joseph Suzow, Scott W. Hiebert, Alan D. Friedman	50

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact